Vivimed Labs Financial Statements
Quarterly
Yearly
| Particulars | Dec '20 | Mar '21 | Jun '21 | Sep '21 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | 277.94 | 38.99 | 65.26 | 54.38 | 56.52 |
| Expenses | 316.32 | 59.47 | 59.00 | 69.20 | 68.26 |
| EBITDA | -38.38 | -20.48 | 6.26 | -14.82 | -11.74 |
| EBIT | -54.90 | -24.61 | 1.73 | -19.17 | -16.19 |
| Profit Before Tax | -50.17 | -27.90 | -2.34 | -23.30 | -23.68 |
| Net Profit | -49.55 | -27.46 | -2.34 | -23.30 | -23.68 |
| Financial Ratios | |||||
| Operating Profit Margin | -13.81% | -52.53% | 9.58% | -27.25% | -20.77% |
| Net Profit Margin | -17.83% | -70.43% | -3.59% | -42.85% | -41.90% |
| Earning Per Share (Diluted) | -5.98 | -3.31 | -0.28 | -2.81 | -2.86 |
| Dividends Per Share | NA | NA | NA | NA | NA |
